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Background
It is known that the circulating Vdelta2 T cell subset
respond to mycobacteria and certain viruses, while the
Vdelta1 subset is resident in the mucosal-asssociated
lymphoid tissue and participate in the immunity against
intracellular microrganisms. We reported that in HIV-1
infected patients circulating Vdelta1 T lymphocytes are
increased; in vitro, these cells can proliferate in response
to Candida albicans. We analysed the effects of influenza
virus vaccination on the function of this T cell subset in
HIV-1 infected patients and healthy donors.
Methods
We analysed the effects of influenza virus vaccination on
the function of Vdelta1 and Vdelta2 T cell subsets in
HIV-1 infected patients and healthy donors. Cells were
isolated from blood samples obtained before and after
30 or 90 days after vaccination. Proliferation to C.albi-
cans and to hemoagglutimnin (HA) was assessed by thy-
midine uptake after 7 days of stimulation.
Results
First, we confirmed that the Vdelta1 T cell subset is
expanded in HIV-1 infected patients (absolute number
of cells/microliter range 28-30 in HIV-1 patients vs. 8-
12 in healthy donors). On day 90 after vaccination the
number of Vdelta1 T cells significantly increased in
HIV-1 patients (59 in the group A, 48 in the group B).
Interestingly, upon influenza vaccination an increase in
proliferation of Vdelta1 T cells to C. albicans was
observed in HIV-1 patients, at variance with healthy
donors, on day 30 and day 90. A specific cellular
response to HA was detectable in HIV-1 patients only
on day 90 post-vaccination without MF59 adjuvant, but
it was observed on day 30, as in seronegative subjects,
when MF59-vaccine was used.
Discussion
We suggest that in HIV-1 infected patients, a population
of Vdelta1 T lymphocytes reactive to C. albicans is pre-
sent in vivo; upon challenge with influenza virus vaccine
this population receives an activation signal possibly
mediated by cytokines triggered by the HA antigen
itself.
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